CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
7.36
3.23%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 7.13
Open 7.23
1-Year Change -4.37%
Day's Range 7.15 - 7.38
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 19, 2024 7.13 -0.11 -1.52% 7.24 7.28 7.10
Jul 18, 2024 7.26 -0.06 -0.82% 7.32 7.54 7.26
Jul 17, 2024 7.44 0.15 2.06% 7.29 7.47 7.22
Jul 16, 2024 7.44 0.28 3.91% 7.16 7.45 7.16
Jul 15, 2024 7.10 -0.02 -0.28% 7.12 7.21 7.06
Jul 12, 2024 7.08 -0.07 -0.98% 7.15 7.21 6.97
Jul 11, 2024 7.07 0.16 2.32% 6.91 7.12 6.89
Jul 10, 2024 6.81 0.03 0.44% 6.78 6.85 6.72
Jul 9, 2024 6.79 0.02 0.30% 6.77 6.79 6.72
Jul 8, 2024 6.77 -0.01 -0.15% 6.78 6.94 6.76
Jul 5, 2024 6.75 -0.03 -0.44% 6.78 6.82 6.66
Jul 3, 2024 6.78 0.02 0.30% 6.76 6.79 6.69
Jul 2, 2024 6.75 -0.08 -1.17% 6.83 6.98 6.68
Jul 1, 2024 6.67 -0.24 -3.47% 6.91 6.95 6.64
Jun 28, 2024 6.90 0.15 2.22% 6.75 6.90 6.67
Jun 27, 2024 6.72 0.07 1.05% 6.65 6.73 6.61
Jun 26, 2024 6.64 -0.02 -0.30% 6.66 6.68 6.56
Jun 25, 2024 6.75 0.00 0.00% 6.75 6.82 6.70
Jun 24, 2024 6.77 -0.08 -1.17% 6.85 6.89 6.70
Jun 21, 2024 6.84 0.07 1.03% 6.77 6.91 6.71

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

MiMedx Company profile

About MiMedx Group Inc

MiMedx Group, Inc. is utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing the needs of patients with acute and chronic non-healing wounds, and a late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company’s platform technologies include AmnioFix, EpiFix, EpiCord, AmnioCord and AmnioFill. Its AmnioFix and EpiFix are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. The EpiCord and AmnioCord are tissue allografts derived from umbilical cord tissue. Its AmnioFill is a particulate product comprised of placental connective tissue matrix, derived from the placental disc and placental membranes.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, MiMedx Group Inc revenues increased 4% to $258.6M. Net loss applicable to common stockholders decreased 80% to $16.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Investigation, restatement and related decrease of 94% to $3.8M (expense), Loss on extinguishment of debt decrease from $8.2M (expense) to

Equity composition

Common Stock $.001 Par, 03/11, 100M auth., 64,331,910 issd., less 50,000 shs. in Treas. @ $25K. Insiders own approx. 18.35%.

Industry: Bio Medical Devices

1775 W Oak Commons Court, Ne
MARIETTA
GEORGIA 30062
US

People also watch

Gold

2,396.84 Price
-0.150% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 21:00 (UTC)
Spread 0.60

BTC/USD

67,917.55 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,790.60 Price
+1.440% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,486.14 Price
-0.480% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading